(Q38215665)

31 August 2017

title

The role of epigenetics in colorectal cancer (English)

1 reference

31 August 2017

1 reference

Fabio Coppedè

1

1 reference

31 August 2017

publication date

29 May 2014

1 reference

Expert Review of Gastroenterology & Hepatology

31 August 2017

published in

1 reference

31 August 2017

volume

8

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

935-948

1 reference

Patterns of colorectal cancer care in the United States and Canada: a systematic review

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Colorectal cancer prevention in Europe: burden of disease and status of screening programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Patterns of colorectal cancer care in Europe, Australia, and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Clinical update: colon, rectal, and anal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Genetics, cytogenetics, and epigenetics of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Epigenetics and colorectal cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

The power and the promise of DNA methylation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Three DNA methylation epigenotypes in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Genome-scale analysis of aberrant DNA methylation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Molecular pathways in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Functions of DNA methylation: islands, start sites, gene bodies and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Methyl-CpG-binding proteins. Targeting specific gene repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Crystal structure of the nucleosome core particle at 2.8 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

The complex language of chromatin regulation during transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

The diverse functions of histone lysine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

MicroRNAs and epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Small RNAs in transcriptional gene silencing and genome defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Long non-coding RNA modifies chromatin: epigenetic silencing by long non-coding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Epigenetics and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Accumulation of aberrant DNA methylation during colorectal cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Serrated lesions of the colorectum: review and recommendations from an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Toward a Molecular Classification of Colorectal Cancer: The Role of MGMT

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Laterally spreading tumors in the colon and rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

The epigenetics of (hereditary) colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

The role of epigenetics in Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Hormone therapy, DNA methylation and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Biomarkers in precision therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Genomic and epigenomic integration identifies a prognostic signature in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

TFAP2E-DKK4 and chemoresistance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Epigenetics of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Histone modifications as a pathogenic mechanism of colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

P300 binds to and acetylates MTA2 to promote colorectal cancer cells growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Global histone modification of histone H3 in colorectal cancer and its precursor lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

The role of microRNA-200 in progression of human colorectal and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

MicroRNA profiling differentiates colorectal cancer according to KRAS status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.924397

10.1586/17474124.2014.924397

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference